MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CCCC has $359,075K in assets. $102,488K in debts. $74,603K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
781.39%
Quick Ratio
781.39%
Cash Ratio
225.85%
Debt to Asset Ratio
28.54%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities, current
    • Cash and cash equivalents
    • Right-of-use asset
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, net o...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
74,603
Marketable securities, current
173,934
Accounts receivable
2,401
Prepaid expenses and other current assets
7,172
Total current assets
258,110
Marketable securities, non-current
48,563
Property and equipment, net
4,744
Right-of-use asset
40,532
Restricted cash
3,443
Other assets
3,683
Total assets
359,075
Accounts payable
858
Accrued expenses and other current liabilities
13,314
Deferred revenue, current
12,493
Operating lease liability, current
6,367
Total current liabilities
33,032
Deferred revenue, net of current
15,841
Operating lease liability, net of current
53,615
Total liabilities
102,488
Common stock, par value of 0.0001 per share 300,000,000 and 150,000,000 shares authorized as of december 31, 2025 and december 31, 2024, and 96,914,418 and 70,625,899 shares issued and outstanding as of december31, 2025 and 2024, respectively
9
Additional paid-in capital
995,221
Accumulated other comprehensive income
50
Accumulated deficit
-738,693
Total stockholders equity
256,587
Total liabilities and stockholders equity
359,075
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities,current$173,934K Cash and cashequivalents$74,603K Prepaid expenses andother current assets$7,172K Accounts receivable$2,401K Total current assets$258,110K Marketable securities,non-current$48,563K Right-of-use asset$40,532K Property and equipment,net$4,744K Other assets$3,683K Restricted cash$3,443K Total assets$359,075K Total liabilities andstockholders equity$359,075K Total stockholdersequity$256,587K Total liabilities$102,488K Accumulated deficit-$738,693K Additional paid-in capital$995,221K Operating leaseliability, net of current$53,615K Total currentliabilities$33,032K Deferred revenue, net ofcurrent$15,841K Accumulated othercomprehensive income$50K Common stock, par valueof 0.0001 per share...$9K Accrued expenses andother current...$13,314K Deferred revenue,current$12,493K Operating leaseliability, current$6,367K Accounts payable$858K

C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics, Inc. (CCCC)